Anterix INC Form 4 insider transactions

Elena Marquez, Chief Financial Officer of Anterix Inc., reported a transaction in 1,325 shares of common stock on September 29, 2026.

Scott A. Lang, President and CEO and a Director of Anterix Inc., sold 15,000 shares of common stock on September 21, 2026 for $80.00 per share.

Heather Martin, Chief Marketing Officer of Anterix Inc., sold 8,064 shares of common stock on September 9, 2026 for $84.20 per share.

Gena L Ashe, Chief Legal Officer & Corp Sec of Anterix Inc., sold 4,357 shares of common stock on September 8, 2026 for $85.44 per share.

Leslie B Daniels, a Director of Anterix Inc., sold 2,500 shares of common stock on September 10, 2026 for $83.83 per share.

Gena L Ashe, Chief Legal Officer & Corp Sec of Anterix Inc., sold 4,357 shares of common stock on September 8, 2026 for $85.44 per share.

Leslie B Daniels, a Director of Anterix Inc., sold 10,100 shares of common stock on September 3, 2026.

Christopher Guttman-Mccabe, Chief Reg & Comm Officer of Anterix Inc., sold 23,439 shares of common stock on August 25, 2026.

Thomas R. Kuhn, a Director of Anterix Inc., sold 11,654 shares of common stock on May 20, 2026.

William Heard, a Director of Anterix Inc., reported a transaction in 5,400 shares of common stock on August 19, 2026.

William Heard, a Director of Anterix Inc., sold 46,400 shares of common stock on August 14, 2026 for $90.11 per share.

Scott A. Lang, President and CEO and a Director of Anterix Inc., sold 35,057 shares of common stock on August 14, 2026.

William Heard, a Director of Anterix Inc., reported a transaction in 1,887 shares of common stock on December 29, 2025.

William Heard, a Director of Anterix Inc., received 1,598 shares of common stock on August 4, 2026.

Jeffrey A Altman and 1 other reported changes in beneficial ownership of Anterix Inc. common stock on August 4, 2026.

Mahvash Yazdi, a Director of Anterix Inc., received 1,598 shares of common stock on August 4, 2026.

Mark Fleischhauer, a Director of Anterix Inc., received 1,598 shares of common stock on August 4, 2026.

Leslie B Daniels, a Director of Anterix Inc., received 1,598 shares of common stock on August 4, 2026.

Elena Marquez, Chief Financial Officer of Anterix Inc., reported a transaction in 231 shares of common stock on July 13, 2026.

Christopher Guttman-Mccabe, Chief Reg & Comm Officer of Anterix Inc., reported a transaction in 1,516 shares of common stock on July 13, 2026.

Anterix Inc. files an amended Form 4 to correct a reporting error regarding beneficial ownership of stock options.

Anterix Inc. Chief Financial Officer Elena Marquez reported transactions involving the acquisition and disposition of company stock, alongside the exercise of stock options.

Anterix Chief Regulatory and Communications Officer Christopher Guttman-McCabe exercised options for 122,852 shares and sold 91,437 shares.

Anterix Inc. Chief Legal Officer Gena L. Ashe exercised stock options and sold a portion of the resulting shares.

Anterix Inc. President and CEO Scott Lang exercised stock options for 138,318 shares, resulting in a net increase in direct ownership.

Anterix Inc. Director Mark Fleischhauer sold 3,500 shares of common stock at an average price of $79.8294.

Anterix Inc. Director and 10% owner Mahvash Yazdi reported the sale of 7,000 common shares at $80 per share, executed under a pre-arranged 10b5-1 trading plan.

Gena L. Ashe, Chief Legal Officer & Corp Sec of Anterix Inc., reported a transaction involving the sale of 2,501 common shares.

Anterix Inc. President and CEO Scott Lang was granted 18,210 restricted stock units and 72,839 stock options on May 20, 2026.

Anterix Inc. Chief Legal Officer Gena L. Ashe was granted 3,694 restricted stock units and 17,453 stock options.